REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
PREDICTSURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PREDICTSURE
ST13
US500000079259194Class
5, 10, 42, 44
Filing
79259194
Registration
6039264
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/29/2025
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
12/18/2018
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BLAZICH,JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PredictImmune Ltd.
Representatives
Shoko Naruo Thompson Coburn LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic and prognostic reagents and preparations for medical purposes; diagnostic and prognostic reagents and preparations for laboratory testing for medical purposesincluding laboratory testing of samples from patients
Class 10
Diagnostic and prognostic apparatusesdevices and instruments for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic test kits comprising test tubestest platesreagents and indicator diagramsfor the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic apparatusesdevices and instruments for medical testing purposes in relation to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis; diagnostic and prognostic test kits comprising test tubestest platesreagents and indicator diagramsfor medical testing purposes in relation to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis
Class 42
Computer-aided diagnostic and prognostic testing servicesincluding analyzing samples from patients to provide diagnosis and prognosis and guiding treatment optionsmedical laboratory services; software as a service (Saas) services featuring software for diagnosis and prognosis of immune-related diseases; software as a service (SaaS) services featuring software for providing diagnostic or prognostic results and guiding treatment options based on data from patient samples; design and development of diagnostic and prognostic apparatusdeviceskits and instruments; medical and scientific researchdesign and development of diagnostic and prognostic testsincluding diagnostic and prognostic tests relating to immune-related diseases including inflammatory bowel diseaseCrohn's diseaseulcerative colitis
Class 44
Medical servicesincluding diagnostic and prognostic servicesguiding treatment options; RNA and DNA analysisgenetic testing for medical purposes; medical analysis services for the diagnosisprognosis and treatment of persons provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
28 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/06/2020
FIMP
FINAL DISPOSITION PROCESSED
08/31/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2019
RFNP
REFUSAL PROCESSED BY IB
07/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/22/2019
RFRR
REFUSAL PROCESSED BY MPU
06/22/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/04/2019
CNRT
NON-FINAL ACTION WRITTEN
06/03/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2019
DOCK
ASSIGNED TO EXAMINER
05/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/23/2019
Continuous trademark protection
Get notified about every new filing that threatens PREDICTSURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.